trending Market Intelligence /marketintelligence/en/news-insights/trending/nkB6rKTe_LMHAoVtr8d0rg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Spark Therapeutics prices common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Spark Therapeutics prices common stock offering

Spark Therapeutics Inc. priced an offering of 4,605,264 common shares at $76 apiece for expected net proceeds of about $330.8 million.

The company also granted underwriters an option to buy up to 690,789 additional shares.

The offering is expected to close by Aug. 9, subject to customary closing conditions.

J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Co. LLC are acting as book-running managers for the offering.